克拉霉素三联疗法治疗幽门螺旋杆菌感染的相关胃炎的临床分析

Clinical Analysis of Clarithromycin in the Treatment of Gastritis Associated With Helicobacter Pylori Infection

目的 研究克拉霉素联合三联疗法治疗幽门螺旋杆菌感染的相关胃炎的临床效果分析,通过对患者治疗后病症的分析,得出能普遍作用于临床操作的治疗措施。方法 总结我县中医院内科2015年1~10月收治的60例门诊患者,观察受幽门螺旋杆菌感染的胃炎患者临床诊断及治疗数据,比较使用克拉霉素三联疗法的治疗效果,得出结论。结果 在治疗效果方面,对照组的有效率为73.33%,治疗组的有效率为95.67%,治疗组的有效率高于对照组,两组的比较差异具有统计学意义,P〈0.05。结论 经研究发现,克拉霉素联合三联疗法治疗幽门螺旋杆菌感染相关胃炎的临床效果显著,无不良反应和副作用。

Objective Study of clarithromycin triple therapy for Helicobacter pylori infection in clinical effect analysis of gastritis associated, through the analysis of disease after treatment, that can generally be applied to clinical treatment. Methods 60 cases of outpatients in my county hospital of traditional Chinese medicine were chosen from January to October 2015, observation of infected by Helicobacter pylori gastritis patients with clinical diagnosis and treatment of data, compare the use of the therapeutic effect of clarithromycin triple therapy, draws the conclusion. Results In the treatment effect, the effective rate of the control group was 73.33%, the effective rate of the treatment group was 95.67%, the effective rate of the treatment group was higher than that of the control group, the difference between the two groups was statistically significant, P0.05. Conclusion The study found no adverse reactions and side effects of clarithromycin combined with triple therapy for treatment of pyloric spirillum infection related gastritis clinical effect significantly.